首页> 外国专利> Substituted dihydroxy-phenylpropyl hydroxy-Oxazopiriminas derivatives, glutamate metabolic receptor (MGLUR) modulators, including the Family Macedonian components of these receptors, and compounds used to treat and/or prevent NCS-related diseases, such as ANSIEDA D, offset, pain, etc.

Substituted dihydroxy-phenylpropyl hydroxy-Oxazopiriminas derivatives, glutamate metabolic receptor (MGLUR) modulators, including the Family Macedonian components of these receptors, and compounds used to treat and/or prevent NCS-related diseases, such as ANSIEDA D, offset, pain, etc.

机译：取代的二羟基-苯基丙基羟基-恶唑嘧啶衍生物，谷氨酸代谢受体（MGLUR）调节剂，包括这些受体的马其顿家族成分，以及用于治疗和/或预防NCS相关疾病的化合物，例如ANSIEDA D，偏移，疼痛等。

页面导航

摘要
著录项
相似文献

摘要

Compounds derived from oxazolopirimidinonas replaced, glutamate receptor modulators (mGluR); Pharmaceutical composition that comprises; use for the treatment of anxiety, Migraine,Schizophrenia, cognitive disorders, Epilepsy and pain.

机译：衍生自恶唑烷吡咯烷酮的化合物，谷氨酸受体调节剂（mGluR）;药物组合物，其包含;用于治疗焦虑症，偏头痛，精神分裂症，认知障碍，癫痫和疼痛。

著录项

公开/公告号CL2012000650A1

专利类型
公开/公告日2012-08-31

原文格式PDF
申请/专利权人 SANOFI;
展开▼

申请/专利号CL20120000650
发明设计人 KOSLEY RAYMOND WALTER JR SHER ROSY.;
展开▼

申请日2012-03-14
分类号A61K31/519;A61K31/522;A61P25/00;C07D498/04;
国家 CL
入库时间 2022-08-21 17:25:20

相似文献

专利
外文文献